Matches in SemOpenAlex for { <https://semopenalex.org/work/W1544335863> ?p ?o ?g. }
- W1544335863 endingPage "557" @default.
- W1544335863 startingPage "549" @default.
- W1544335863 abstract "BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective study was to identify risk factors for VTE in NDMM and evaluate the effectiveness of LMWH. METHODS: A total of 604 patients with newly diagnosed myeloma completed 3 induction cycles with multiagent chemotherapy with up-front randomization to thalidomide between 1998 and 2004. Prophylactic enoxaparin was given to thalidomide recipients beginning in June 2001, and 122 subjects received prophylactic epoetin alfa (EPO) as part of an exercise trial. The primary study endpoint was grades 3-4 VTE. RESULTS: A total of 72 patients (11.9%) developed VTE (mostly deep venous thrombosis), with a higher incidence among EPO recipients (P = .001), although only significant for upper extremity DVT (P = .0002). The EPO-treated patients had higher hemoglobin (Hb) levels throughout the study (P < .0005), although no relationship between higher Hb levels and increasing incidence of VTE could be shown. A history of VTE was a strong predictor of VTE on univariate analysis (P < .000005). Enoxaparin did not reduce the rate of VTE (P = .158). Logistic regression analysis identified thalidomide therapy (P = .001; odds ratio [OR], 2.428; 95% confidence interval [CI], 1.418-4.159) and prophylactic EPO (P = .002; OR, 2.488; 95% CI, 1.432-4.324) as risk factors for VTE. Myeloma response and survival were not negatively affected by prophylactic EPO or VTE. CONCLUSIONS: Prophylactic EPO, thalidomide therapy, and VTE history, but not higher Hb levels, were found to increase the risk of VTE among NDMM patients receiving multiagent chemotherapy. This risk was not found to be reduced in this population by LMWH thromboprophylaxis. Cancer 2011;. © 2011 American Cancer Society." @default.
- W1544335863 created "2016-06-24" @default.
- W1544335863 creator A5000879635 @default.
- W1544335863 creator A5007152490 @default.
- W1544335863 creator A5007325695 @default.
- W1544335863 creator A5015235499 @default.
- W1544335863 creator A5055180816 @default.
- W1544335863 creator A5059531358 @default.
- W1544335863 creator A5060125360 @default.
- W1544335863 creator A5066480111 @default.
- W1544335863 creator A5088441096 @default.
- W1544335863 date "2011-06-30" @default.
- W1544335863 modified "2023-09-27" @default.
- W1544335863 title "Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis" @default.
- W1544335863 cites W1573083214 @default.
- W1544335863 cites W1966988081 @default.
- W1544335863 cites W1978808454 @default.
- W1544335863 cites W1996552399 @default.
- W1544335863 cites W2002189627 @default.
- W1544335863 cites W2009214551 @default.
- W1544335863 cites W2013029269 @default.
- W1544335863 cites W2024159843 @default.
- W1544335863 cites W2032513431 @default.
- W1544335863 cites W2035056966 @default.
- W1544335863 cites W2039511225 @default.
- W1544335863 cites W2051822316 @default.
- W1544335863 cites W2054489060 @default.
- W1544335863 cites W2070331984 @default.
- W1544335863 cites W2076324806 @default.
- W1544335863 cites W2076716376 @default.
- W1544335863 cites W2088348963 @default.
- W1544335863 cites W2088658609 @default.
- W1544335863 cites W2097331346 @default.
- W1544335863 cites W2098254080 @default.
- W1544335863 cites W2103660186 @default.
- W1544335863 cites W2107853873 @default.
- W1544335863 cites W2109113725 @default.
- W1544335863 cites W2111165803 @default.
- W1544335863 cites W2115099946 @default.
- W1544335863 cites W2116041145 @default.
- W1544335863 cites W2127206962 @default.
- W1544335863 cites W2129538099 @default.
- W1544335863 cites W2132918724 @default.
- W1544335863 cites W2136373453 @default.
- W1544335863 cites W2137984904 @default.
- W1544335863 cites W2138343003 @default.
- W1544335863 cites W2142386661 @default.
- W1544335863 cites W2150250025 @default.
- W1544335863 cites W2154367023 @default.
- W1544335863 cites W2165065963 @default.
- W1544335863 cites W2168658598 @default.
- W1544335863 cites W2403580696 @default.
- W1544335863 cites W2476976684 @default.
- W1544335863 cites W2979556299 @default.
- W1544335863 cites W3205081673 @default.
- W1544335863 cites W4244723148 @default.
- W1544335863 doi "https://doi.org/10.1002/cncr.26302" @default.
- W1544335863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21720994" @default.
- W1544335863 hasPublicationYear "2011" @default.
- W1544335863 type Work @default.
- W1544335863 sameAs 1544335863 @default.
- W1544335863 citedByCount "45" @default.
- W1544335863 countsByYear W15443358632012 @default.
- W1544335863 countsByYear W15443358632013 @default.
- W1544335863 countsByYear W15443358632014 @default.
- W1544335863 countsByYear W15443358632015 @default.
- W1544335863 countsByYear W15443358632016 @default.
- W1544335863 countsByYear W15443358632017 @default.
- W1544335863 countsByYear W15443358632018 @default.
- W1544335863 countsByYear W15443358632019 @default.
- W1544335863 countsByYear W15443358632020 @default.
- W1544335863 countsByYear W15443358632021 @default.
- W1544335863 countsByYear W15443358632022 @default.
- W1544335863 countsByYear W15443358632023 @default.
- W1544335863 crossrefType "journal-article" @default.
- W1544335863 hasAuthorship W1544335863A5000879635 @default.
- W1544335863 hasAuthorship W1544335863A5007152490 @default.
- W1544335863 hasAuthorship W1544335863A5007325695 @default.
- W1544335863 hasAuthorship W1544335863A5015235499 @default.
- W1544335863 hasAuthorship W1544335863A5055180816 @default.
- W1544335863 hasAuthorship W1544335863A5059531358 @default.
- W1544335863 hasAuthorship W1544335863A5060125360 @default.
- W1544335863 hasAuthorship W1544335863A5066480111 @default.
- W1544335863 hasAuthorship W1544335863A5088441096 @default.
- W1544335863 hasConcept C120665830 @default.
- W1544335863 hasConcept C121332964 @default.
- W1544335863 hasConcept C126322002 @default.
- W1544335863 hasConcept C141071460 @default.
- W1544335863 hasConcept C156957248 @default.
- W1544335863 hasConcept C2776364478 @default.
- W1544335863 hasConcept C2776688490 @default.
- W1544335863 hasConcept C2776884760 @default.
- W1544335863 hasConcept C2779609412 @default.
- W1544335863 hasConcept C2780868729 @default.
- W1544335863 hasConcept C61511704 @default.
- W1544335863 hasConcept C71924100 @default.
- W1544335863 hasConceptScore W1544335863C120665830 @default.
- W1544335863 hasConceptScore W1544335863C121332964 @default.